4/A//SEC Filing
SYNTA PHARMACEUTICALS CORP 4/A
Accession 0001179110-15-014821
$MDGLCIK 0001157601operating
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 11:20 AM ET
Size
6.9 KB
Accession
0001179110-15-014821
Insider Transaction Report
Form 4/AAmended
Gollust Keith R
Director
Transactions
- Sale
Common Stock
2015-11-10$0.55/sh−188,322$103,050→ 2,985,061 total(indirect: By Wyandanch Partners, L.P.)
Holdings
- 401,764
Common Stock
- 175,000(indirect: By IRA)
Common Stock
Footnotes (3)
- [F1]This Form 4/A is being filed to correct a typographical error. Box 4 of the original Form 4 filed November 12, 2015 should have stated that the securities were disposed of by the Reporting Person, not acquired.
- [F2]This transaction was executed in multiple trades at prices ranging from $0.5373 to $0.5537 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 11:20 AM ET
- Size
- 6.9 KB